Lumos Diagnostics services

Lumos manages the full development program for point-of-care (POC) assays, from sourcing and/or generation of reagents, right through to verification and validation. With the acquisition of Kestrel BioSciences, the Lumos team brings over 30 years of experience in lateral flow assay development and market knowledge.

Lumos Diagnostics has developed a digital cloud platform, that enables our partners to leverage the cloud to create an entire product ecosystem and enhance reader capability. We work collaboratively with you to customize our platform and develop a specific solution that fits your exact needs.

Lumos has a wide range of experience in POC reader development, from flexible laboratory systems through to portable disposable devices suitable for in field use. By using Lumos’s existing reader optical technologies, the development timeline, cost and product risk are reduced, resulting in a faster time to market. Lumos is able to tailor the final product to match our partners` performance, cost and regulatory requirements.